Evidence map›Paper›PMID 42259831›Full record

ArticleNPJ breast cancer2026

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.

François-Clement Bidard, Carlos Barrios, Giampaolo Bianchini, Adam M Brufsky, Stephen Chia, Javier Cortes, Massimo Cristofanilli, Giuseppe Curigliano, Shaheenah Dawood, Peter A Fasching and 22 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

François-Clement BidardDepartment of Medical Oncology, Inserm CIC 2501, Institut Curie, Paris, France. francois-clement.bidard@curie.fr.
Carlos BarriosLatin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Giampaolo BianchiniDepartment of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
Adam M BrufskyUPMC Magee-Womens Hospital, Pittsburgh, PA, USA.
Stephen ChiaBC Cancer - Vancouver Cancer Centre, Vancouver, BC, Canada.
Javier CortesInternational Breast Cancer Center (IBCC), Pangaea Oncology, Quirón Group, Barcelona, Spain.
Massimo CristofanilliDepartment of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.
Giuseppe CuriglianoDepartment of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
Shaheenah DawoodMediclinic Hospital, Dubai, United Arab Emirates.
Peter A FaschingDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.
Lorenzo GerratanaDepartment of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
Antonio GiordanoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Michail IgnatiadisInstitut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B.), Université libre de Bruxelles (ULB), Brussels, Belgium.
Hiroji IwataGraduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
Wolfgang JanniDepartment of Obstetrics and Gynecology, University Hospital Ulm, Ulm, Germany.
Elgene LimGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Kevin KalinskyDepartment of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Cynthia X MaDivision of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Erica L MayerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Arielle J MedfordHarvard Medical School, Boston, MA, USA.
Jason A MouabbiDivision of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Joyce O'ShaughnessyBaylor University Medical Center, Dallas, TX, USA.
Yeon Hee ParkDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Javier PascualMedical Oncology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain.
Pedram RazaviDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sarah SammonsHarvard Medical School, Boston, MA, USA.
José Luis SandovalDepartment of Medical Oncology, Inserm CIC 2501, Institut Curie, Paris, France.
Luisana SiscaDepartment of Medical Oncology, Inserm CIC 2501, Institut Curie, Paris, France.
Paolo TarantinoDana-Farber Brigham Cancer Center, Boston, MA, USA.
Seth A WanderDepartment of Medical Oncology, Mass General Brigham Cancer Institute, Harvard Medical School, Boston, MA, USA.
Gustavo WerutskyLatin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
Nicholas A TurnerRoyal Marsden NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42259831
PMCPMC13247249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.